Changes in arterial blood pressure after single oral administration of cuttlefish (Sepia officinalis) muscle derived peptides in spontaneously hypertensive rats

Journal of Functional Foods

Volumn 4, Issue 3, 2012, Pages 611-617

  Balti, Rafik ^a,b   Bougatef, Ali ^a   Guillochon, Didier ^b   Dhulster, Pascal ^b   Nasri, Moncef ^a   Nedjar Arroume, Naima ^b  

^a UNIVERSITY OF SFAX   (Tunisia)

^b UNIV LILLE   (France)

Author keywords

Antihypertensive peptides; Arterial blood pressure; Cuttlefish muscle; Sepia officinalis; Spontaneously hypertensive rats

Indexed keywords

ANIMALIA; RATTUS; SEPIA OFFICINALIS; SEPIIDAE;

EID: 84861683144     PISSN: 17564646     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jff.2012.03.007     Document Type: Article

References (44)

1. Atherton E., Sheppard R.C. Solid Phase Synthesis. A Practical Approach 1989, IRL Press, Oxford.
2. Atkinson A.B., Robertson J.I. Captopril in the treatment of clinical hypertension and cardiac failure. Lancet 1979, 2:836-839.
3. Balti R., Nedjar-Arroume N., Yaba Adjé E., Guillochon D., Nasri M. Analysis of novel angiotensin I-converting enzyme inhibitory peptides from enzymatic hydrolysates of Cuttlefish (Sepia officinalis) muscle proteins. Journal of Agricultural and Food Chemistry 2010, 58:3840-3846.
4. Balti R., Nedjar-Arroume N., Bougatef A., Guillochon D., Nasri M. Three novel angiotensin I converting enzyme (ACE) inhibitory peptides from cuttlefish (Sepia officinalis) using digestive proteases. Food Research International 2010, 43:1136-1143.
5. Boelsma E., Kloek J. Lactotripeptides and antihypertensive effects: a critical review. British Journal of Nutrition 2009, 101:776-786.
6. Bunag R.D. Validation in awake rats of a tail-cuff method for measuring systolic pressure. Journal of Applied Physiology 1973, 34:279-282.
7. Chen Z.Y., Peng C., Jiao R., Wong Y.M., Yang N., Huang Y. Anti-hypertensive nutraceuticals and functional foods. Journal of Agricultural and Food Chemistry 2009, 57:4485-4499.
8. Cheung H.S., Wang F.L., Ondetti M.A., Sabo E.F., Cushman D.W. Binding of peptides substrates and inhibitors of angiotensin-converting enzyme. The Journal of Biological Chemistry 1980, 25:401-407.
9. Chobanian A.V., Bakris G.L., Black H.R., Cushman W.C., Green L.A., Izzo J.L., Jones D.W., Materson B.J., Oparil S., Wright J.T., Roccella E.J. Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. National Heart, Lung, and Blood Institute; National High Blood Pressure Education Program Coordinating Committee. Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension 2003, 42:1206-1252.
10. Contreras M.D., Carron R., Montero M.J., Ramos M., Recio I. Novel casein-derived peptides with antihypertensive activity. International Dairy Journal 2009, 19:566-573.
11. Cushman D.W., Cheung H.S., Sabo E.F., Ondetti M.A. Design of potent competitive inhibitors of angiotensin-converting enzyme. Carboxyalkanoyl and mercaptoalkanoyl amino acids. Biochemistry 1977, 16:5484-5491.
12. Davalos A., Miguel M., Bartolome B., Lopez-Fandino R. Antioxidant activity of peptides derived from egg white proteins by enzymatic hydrolysis. Journal of Food Protection 2004, 67:1939-1944.
13. Fitzgerald C., Gallagher E., Tasdemir D., Hayes M. Heart health peptides from macroalgae and their potential use in functional foods. Journal of Agricultural and Food Chemistry 2011, 59:6829-6836.
14. FitzGerald R.J., Murray B.A., Walsh G.J. Hypotensive peptides from milk proteins. The Journal of Nutrition 2004, 134:980-988.
15. Fujita H., Yoshikawa M. LKPNM: a prodrug-type ACE inhibitory peptide derived from fish protein. Immunopharmacology 1999, 44:123-127.
16. Hernández-Ledesma B., del Mar Contreras M., Recio I. Antihypertensive peptides: production, bioavailability and incorporation into foods. Advances in Colloid and Interface Science 2011, 165:23-35.
17. Hirota T., Ohki K., Kawagishi R., Kajimoto Y., Mizuno S., Nakamura Y., Kitakaze M. Casein hydrolysate containing the antihypertensive tripeptides Val-Pro-Pro and Ile-Pro-Pro improves vascular endothelial function independent of blood pressure-lowering effects: contribution of the inhibitory action of angiotensin converting enzyme. Hypertension Research 2007, 30:489-496.
18. Huang W.H., Sun J., He H., Dong H.W., Li J.T. Antihypertensive effect of corn peptides produced by a continuous production in enzymatic membrane reactor, in spontaneously hypertensive rats. Food Chemistry 2011, 128:968-973.
19. Lee S.H., Qian Z.J., Kim S.K. A novel angiotensin I converting enzyme inhibitory peptide from tuna frame protein hydrolysate and its antihypertensive effect in spontaneously hypertensive rats. Food Chemistry 2010, 118:96-102.
20. Masuda O., Nakamura Y., Takano T. Antihypertensive peptides are present in aorta after oral administration of sour milk containing these peptides to spontaneously hypertensive rats. The Journal of Nutrition 1996, 126:3063-3068.
21. Miguel M., Muguerza B., Sanchez E., Delgado M.A., Recio I., Ramos M., Aleixandre M.A. Changes in arterial blood pressure of milk fermented by Enterococcus faecalis CECT 5728 in spontaneously hypertensive rats. British Journal of Nutrition 2005, 93:1-9.
22. Miguel M., Lopez-Fandino R., Ramos M., Aleixandre M.A. Long-term antihypertensive effect of egg white treated with pepsin in hypertensive rats. Life Science 2006, 78:2960-2966.
23. Miguel M., Recio I., Ramos M., Delgado M.A., Aleixandre M.A. Effect of ACE-inhibitory peptides obtained from Enterococcus faecalis fermented milk in hypertensive rats. Journal of Dairy Science 2006, 89:3352-3359.
24. Miguel M., Manso M.A., Aleixandre M.A., Lopez- Fandino R. Angiotensin converting enzyme activity in plasma and tissues of spontaneously hypertensive rats after short- and long-term intake of an egg white hydrolysate. Molecular Nutrition and Food Research 2007, 51:555-563.
25. Miguel M., Alvarez Y., Lopez-Fandino R., Alonso M.J., Salaices M. Vascular effects of peptides derived from egg white proteins. Regulatory Peptides 2007, 140:131-135.
26. Miura K., Daviglus M.L., Dyer A.R., Liu K., Garside D.B., Stamler J., Greenland P. Relationship of blood pressure to 25-year mortality due to coronary heart disease, cardiovascular diseases, and all causes in young adult men: the Chicago Heart Association Detection Project in Industry. Archives of Internal Medicine 2001, 161:1501-1508.
27. Nakamura Y., Yamamoto N., Sakai K., Okubo A., Yamazaki S., Takano T. Purification and characterization of angiotensin I-converting-enzyme inhibitors from sour milk. Journal of Dairy Science 1995, 78:777-783.
28. Nakamura Y., Yamamoto N., Sakai K.Y., Takano T. Antihypertensive effect of sour milk and peptides isolated from it that are inhibitors to angiotensin I converting enzyme. Journal of Dairy Science 1995, 78:1253-1257.
29. Nakamura Y., Masuda O., Takano T. Decrease of tissue angiotensin I-converting enzyme activity upon feeding sour milk in spontaneously hypertensive rats. Bioscience Biotechnology and Biochemistry 1996, 60:488-489.
30. Okamoto K., Aoki K. Development of a strain of spontaneously hypertensive rats. Japanese Circulation Journal 1963, 27:282-293.
31. Olejnik S., Li J., Supattathum S., Huberty C.J. Multiple testing and statistical power with modified Bonferroni procedures. Journal of Educational and Behavioral Statistics 1997, 22:389-406.
32. Ondetti M.A. Design of specific inhibitors of angiotensin converting enzyme: new class of orally active antihypertensive agents. Science 1977, 196:441-444.
33. Quiros A., Ramos M., Muguerza B., Delgado M.A., Miguel M., Aleixandre A., Recio I. Identification of novel antihypertensive peptides in milk fermented with Enterococcus faecalis. International Dairy Journal 2007, 17:33-41.
34. Sekiya S., Kobayashi Y., Kita E., Imamura Y., Toyama S. Antihypertensive effects of tryptic hydrolysate of casein on normotensive and hypertensive volunteers. Journal of Nutrition and Food Sciences 1992, 45:513-517.
35. Seppo L., Jauhiainen T., Poussa T., Korpela R.A. A fermented milk high in bioactive peptides has a blood pressure-lowering effect in hypertensive subjects. American Journal of Clinical Nutrition 2003, 77:326-330.
36. Sipola M., Finckenberg P., Santisteban J., Korpela R., Vapaatalo H., Nurminen M.L. Long-term intake of milk peptides attenuates development of hypertension in spontaneously hypertensive rats. Journal of physiology and pharmacology 2001, 52:745-754.
37. Skeggs L.T., Kahn J.R., Shumway N.P. The isolation and assay of hypertension from blood. Journal of Experimental Medicine 1952, 95:241-246.
38. Sood N., Reinhart K.M., Baker W.L. Combination therapy for the management of hypertension: a review of the evidence. American Journal of Health-System Pharmacy 2010, 67:885-894.
39. Usinger L., Ibsen H., Jensen L.T. Does fermented milk possess antihypertensive effect in humans?. Journal of Hypertension 2009, 27:1115-1120.
40. Verdecchia P., Angeli F., Mazzotta G., Gentile G., Reboldi G. The renin angiotensin system in the development of cardiovascular disease: role of aliskiren in risk reduction. Vascular Health and Risk Management 2008, 4:971-981.
41. Vermeirssen V., Van Camp J., Verstraete W. Bioavailability of angiotensin I converting enzyme inhibitory peptides. British Journal of Nutrition 2004, 92:357-366.
42. Wang J., Hu J., Cui J., Bai X., Dua Y., Miyaguchi Y., Lin B. Purification and identification of a ACE inhibitory peptide from oyster proteins hydrolysate and the antihypertensive effect of hydrolysate in spontaneously hypertensive rats. Food Chemistry 2008, 111:302-308.
43. Xu J.Y., Qin L.Q., Wang P.Y., Li W., Chang C. Effect of milk tripeptides on blood pressure: a meta-analysis of randomized controlled trials. Nutrition 2008, 24:933-940.
44. Yang H.Y., Yang S.C., Chen J.R., Tzeng Y.H., Han B.C. Soybean protein hydrolysate prevents the development of hypertension in spontaneously hypertensive rats. British Journal of Nutrition 2004, 92:507-512.